Page last updated: 2024-10-30

mecamylamine and Anasarca

mecamylamine has been researched along with Anasarca in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexandre, M1
Uduman, AK1
Minervini, S1
Raoof, A1
Shugrue, CA1
Akinbiyi, EO1
Patel, V1
Shitia, M1
Kolodecik, TR1
Patton, R1
Gorelick, FS1
Thrower, EC1

Other Studies

1 other study available for mecamylamine and Anasarca

ArticleYear
Tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone initiates and enhances pancreatitis responses.
    American journal of physiology. Gastrointestinal and liver physiology, 2012, Sep-15, Volume: 303, Issue:6

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Atropine; Carcinogens; Cells, Cultured; Ceruletide

2012